Pembrolizumab as consolidation strategy in patients with multiple myeloma : Results of the GEM-pembresid clinical trial

PD1 expression in CD4 and CD8 T cells is increased after treatment in multiple myeloma patients with persistent disease. The GEM-Pembresid trial analyzed the efficacy and safety of pembrolizumab as consolidation in patients achieving at least very good partial response but with persistent measurable...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Puig, N, Corchete Sánchez, Luis Antonio, Pérez-Morán, J. J, Dávila, J, Paíno, T, de la Rubia, Javier, Oriol, Albert, Martín-Sánchez, J, De Arriba, Felipe, Bladé Creixenti, Juan, Blanchard, María Jesús, González-Calle, Verónica, García-Sanz, Ramón, Paiva, Bruno, Lahuerta, J. J, San-Miguel, J. F, Mateos, M. V, Ocio, E. M, Universitat Autònoma de Barcelona
Format:	Artikel
Sprache:	eng
Schlagworte:	Consolidation Immunotherapy Myeloma Pembrolizumab
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!